| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 16 | +56.25% | +0.86% | +1.20% | -0.34% | +0.31% | — |
| 14d | 16 | +56.25% | -4.26% | +2.52% | -6.78% | -2.57% | — |
| 30d | 16 | +62.50% | +5.42% | +2.05% | +3.37% | +4.93% | — |
| 60d | 16 | +75.00% | +20.77% | +7.72% | +13.06% | +20.74% | — |
| 90d | 16 | +93.75% | +39.18% | +12.99% | +30.39% | +36.73% | — |
| 180d | 16(1 pending) | +13.33% | -12.43% | +19.78% | -32.20% | -33.89% | — |
| 1y | 16(1 pending) | +60.00% | +7.14% | +36.36% | -29.21% | -27.53% | — |
| 2y | 16(1 pending) | +0.00% | -79.59% | +57.49% | -137.08% | -134.44% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KARD KARDIGAN, INC. | PURCHASE | 1,250,000 | $16.00 | $20.00M | 15,042,035 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 2,306,401 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | PURCHASE | 13,792,035 | — | — | 13,792,035 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 5,148,587 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 1,204,000 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jun 5, 2026 | Jun 8, 2026 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Jun 4, 2026 | Jun 5, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASE | 488,090 | $25.61 | $12.50M | 1,426,528 | Mar 6, 2026 | Mar 9, 2026 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,915,700 | $2.61 | $5.00M | 6,046,907 | Oct 27, 2025 | Oct 29, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 3,030,300 | $3.30 | $10.00M | 6,230,300 | Aug 1, 2025 | Aug 1, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 39,062 | — | — | 0 | Aug 1, 2025 | Aug 5, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 45,000 | — | — | 0 | Aug 1, 2025 | Aug 5, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Aug 1, 2025 | Aug 5, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 39,062 | — | — | 39,062 | Aug 1, 2025 | Aug 5, 2025 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 130,000 | — | — | 130,000 | Jun 14, 2024 | Jun 17, 2024 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Jun 12, 2024 | Jun 12, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 11,924,138 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 20,000,000 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | PURCHASE | 3,728,738 | — | — | 3,728,738 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 54,278 | — | — | 54,278 | Jun 6, 2024 | Jun 7, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jun 6, 2024 | Jul 15, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 8,000 | — | — | 584,148 | May 30, 2024 | Jun 3, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 16,000 | — | — | 16,000 | May 30, 2024 | Jun 3, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 454,212 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 787,545 | — | — | 828,570 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 201,465 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 586,080 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 589,743 | — | — | 617,092 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 66,667 | $16.00 | $1.07M | 683,759 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 366,301 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 227,920 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 424,908 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 133,333 | $16.00 | $2.13M | 1,181,766 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 164,835 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 1,048,433 | — | — | 1,048,433 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 3,200,000 | $6.25 | $20.00M | 3,200,000 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 727,272 | $5.50 | $4.00M | 12,446,022 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 363,637 | $5.50 | $2.00M | 10,667,387 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,176,593 | — | — | 2,321,566 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 703,061 | — | — | 1,387,228 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 3,357 | $11.98 | $40.2K | 4,131,207 | Nov 14, 2023 | Nov 15, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 31,653 | $11.75 | $371.9K | 4,127,850 | Nov 13, 2023 | Nov 15, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 5,431 | $11.75 | $63.8K | 4,096,197 | Nov 10, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 11,844 | $11.37 | $134.7K | 4,090,766 | Nov 10, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 31,079 | $10.53 | $327.3K | 4,078,922 | Nov 9, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 23,124 | $11.79 | $272.6K | 4,047,843 | Nov 8, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 69,127 | $10.78 | $745.2K | 4,024,719 | Nov 8, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 30,192 | $11.50 | $347.2K | 3,955,592 | Nov 7, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 43,082 | $11.55 | $497.6K | 3,925,400 | Nov 6, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 22,420 | $11.38 | $255.1K | 3,882,318 | Nov 3, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 34,560 | $13.98 | $483.1K | 3,859,898 | Sep 29, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 16,841 | $13.06 | $219.9K | 3,800,228 | Sep 28, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 25,110 | $13.69 | $343.8K | 3,825,338 | Sep 28, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 24,504 | $12.31 | $301.6K | 3,783,387 | Sep 27, 2023 | Sep 27, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 34,000 | $11.73 | $398.8K | 3,758,883 | Sep 26, 2023 | Sep 27, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 30,773 | $10.80 | $332.3K | 3,694,916 | Sep 25, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 29,967 | $11.65 | $349.1K | 3,724,883 | Sep 25, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 40,000 | $11.14 | $445.6K | 3,664,143 | Sep 22, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 6,895,021 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 684,167 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 6,576,400 | — | — | 11,886,758 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 6,576,400 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 2,124,143 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 6,895,021 | — | — | 12,205,379 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,144,973 | — | — | 1,144,973 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 2,124,143 | — | — | 2,124,143 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,500,000 | $17.00 | $25.50M | 3,624,143 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 684,167 | — | — | 684,167 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 1,144,973 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 55,000 | — | — | 55,000 | Sep 8, 2023 | Sep 8, 2023 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jun 16, 2023 | Jun 20, 2023 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASEGRANT Stock grant | 39,062 | — | — | 39,062 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jun 8, 2023 | Jun 12, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 12,054 | — | — | 12,054 | May 22, 2023 | May 24, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 6,027 | — | — | 576,148 | May 22, 2023 | May 24, 2023 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 536 | — | — | 1,353 | Jan 5, 2023 | Jan 6, 2023 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 400,000 | $17.00 | $6.80M | 6,128,297 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 16,666,667 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 16,080 | — | — | 16,080 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 49,999 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 16,666,664 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 5,728,297 | — | — | 5,728,297 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 1,141,474 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 321 | — | — | 817 | Oct 5, 2022 | Oct 6, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 239,559 | — | — | 5,626,008 | Sep 6, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 310,441 | — | — | 7,290,655 | Sep 6, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,850 | — | — | 33,893 | Sep 6, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 30,238 | — | — | 570,121 | Sep 6, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 196,003 | — | — | 5,865,567 | Sep 2, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 253,997 | — | — | 7,601,096 | Sep 2, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 24,737 | — | — | 539,883 | Sep 2, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,508 | — | — | 32,043 | Sep 2, 2022 | Sep 7, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 7,855,093 | Aug 31, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 6,061,570 | Aug 31, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 515,146 | Aug 31, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 30,535 | Aug 31, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 8,137,312 | Aug 30, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 6,279,351 | Aug 30, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 28,851 | Aug 30, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 487,657 | Aug 30, 2022 | Sep 1, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 8,419,531 | Aug 25, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 6,497,132 | Aug 25, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 460,168 | Aug 25, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 27,167 | Aug 25, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 6,714,913 | Aug 24, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 8,701,750 | Aug 24, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 432,679 | Aug 24, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 25,483 | Aug 24, 2022 | Aug 26, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 8,983,969 | Aug 18, 2022 | Aug 22, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 6,932,694 | Aug 18, 2022 | Aug 22, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 405,190 | Aug 18, 2022 | Aug 22, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 23,799 | Aug 18, 2022 | Aug 22, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 7,150,475 | Aug 16, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 22,115 | Aug 16, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 9,266,188 | Aug 16, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 377,701 | Aug 16, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 9,548,407 | Aug 15, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 7,368,256 | Aug 15, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 20,431 | Aug 15, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 350,212 | Aug 15, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 7,586,037 | Aug 12, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 9,830,626 | Aug 12, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 322,723 | Aug 12, 2022 | Aug 16, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 18,747 | Aug 12, 2022 | Aug 16, 2022 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 266 | — | — | 496 | Jul 5, 2022 | Jul 7, 2022 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 10,112,845 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 1,684 | — | — | 17,063 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 7,803,818 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 27,489 | — | — | 295,234 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Jun 6, 2022 | Jun 8, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 8,021,599 | Jun 2, 2022 | Jun 6, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 10,395,064 | Jun 2, 2022 | Jun 6, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 29,173 | — | — | 283,124 | Jun 2, 2022 | Jun 6, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 6,405 | — | — | 253,951 | May 23, 2022 | May 25, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 12,810 | — | — | 12,810 | May 23, 2022 | May 25, 2022 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 230 | — | — | 230 | Apr 5, 2022 | Apr 6, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 102,041 | — | — | 247,546 | Dec 20, 2021 | May 10, 2022 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 762,233 | — | — | 8,239,380 | Dec 20, 2021 | Dec 22, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 987,767 | — | — | 10,677,283 | Dec 20, 2021 | Dec 22, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 102,041 | — | — | 244,172 | Dec 20, 2021 | Dec 22, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 11,665,050 | Nov 29, 2021 | Dec 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 9,001,613 | Nov 29, 2021 | Dec 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 29,153 | — | — | 142,131 | Nov 29, 2021 | Dec 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 9,219,394 | Nov 22, 2021 | Nov 22, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 29,153 | — | — | 112,978 | Nov 22, 2021 | Nov 22, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 11,947,269 | Nov 22, 2021 | Nov 22, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 1,133,333 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 5,527,777 | — | — | 5,527,777 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 3,400,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 2,100,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 1,742,248 | — | — | 9,437,175 | Jul 1, 2021 | Jul 6, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 2,257,752 | — | — | 12,229,488 | Jul 1, 2021 | Jul 6, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 47,897 | — | — | 83,825 | Jul 1, 2021 | Jul 6, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 811 | — | — | 4,867 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 2,921,519 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,555 | — | — | 15,328 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,686 | — | — | 28,111 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 2,921,520 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,121,520 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,121,519 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 811 | — | — | 4,056 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,555 | — | — | 12,773 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,686 | — | — | 23,425 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,321,519 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,321,520 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,555 | — | — | 10,218 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 811 | — | — | 3,245 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,686 | — | — | 18,739 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 435,562 | — | — | 11,179,423 | Jun 22, 2021 | Jun 24, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 564,438 | — | — | 14,487,240 | Jun 22, 2021 | Jun 24, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 11,974 | — | — | 35,928 | Jun 22, 2021 | Jun 24, 2021 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE | 17,771,216 | — | — | 0 | Jun 21, 2021 | Jun 23, 2021 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE | 435,142 | — | — | 0 | Jun 21, 2021 | Jun 23, 2021 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASE | 18,206,358 | — | — | 18,206,358 | Jun 21, 2021 | Jun 23, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 2,074 | — | — | 12,432 | Jun 2, 2021 | Jun 4, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 6,222 | — | — | 6,222 | Jun 2, 2021 | Jun 4, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | SALE | 3,253 | — | — | 0 | Jun 1, 2021 | Jun 3, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASE | 3,253 | — | — | 10,358 | Jun 1, 2021 | Jun 3, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 3,374 | — | — | 27,328 | May 21, 2021 | May 25, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 6,748 | — | — | 6,748 | May 21, 2021 | May 25, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | SALE | 500,000 | — | — | 9,668,749 | May 12, 2021 | Jun 3, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASE | 2,537 | — | — | 7,105 | May 12, 2021 | Jun 3, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 12,500 | — | — | 12,500 | Apr 21, 2021 | Apr 27, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 15,051,678 | Apr 8, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 11,614,985 | Apr 8, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 5,989 | — | — | 23,954 | Apr 8, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 15,333,897 | Apr 7, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 11,832,766 | Apr 7, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 5,989 | — | — | 17,965 | Apr 7, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 15,616,116 | Apr 1, 2021 | Apr 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 12,050,547 | Apr 1, 2021 | Apr 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 5,987 | — | — | 11,976 | Apr 1, 2021 | Apr 1, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,521,519 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,521,520 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,686 | — | — | 14,053 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 217,781 | — | — | 12,268,328 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE | 282,219 | — | — | 15,898,335 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE | 5,989 | — | — | 5,989 | Mar 30, 2021 | Apr 1, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,721,520 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,721,519 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,684 | — | — | 9,367 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | SALE | 500,000 | — | — | 10,168,749 | Mar 22, 2021 | Jun 3, 2021 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASE | 2,538 | — | — | 4,568 | Mar 22, 2021 | Jun 3, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,921,520 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,921,519 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,683 | — | — | 4,683 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 3,687,500 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 11,718,750 | — | — | 11,718,750 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 10,156,250 | — | — | 10,301,250 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 781,250 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 5,687,500 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 2,343,750 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 10,156,250 | — | — | 10,303,750 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 9,375,000 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,000 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 23,591 | — | — | 23,591 | Feb 3, 2021 | Feb 18, 2021 ↗ | View → |
| MASS 908 DEVICES INC. | SALE | 180,578 | — | — | 0 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | SALE | 981,443 | — | — | 0 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | SALE | 669,977 | — | — | 0 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | SALE | 665,661 | — | — | 0 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | SALE | 2,927,386 | — | — | 0 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | PURCHASE | 300,000 | $20.00 | $6.00M | 5,725,045 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| MASS 908 DEVICES INC. | PURCHASE | 5,425,045 | — | — | 5,425,045 | Dec 22, 2020 | Dec 22, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | SALE | 277,514 | — | — | 1,905,481 | Nov 24, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | SALE | 176,920 | — | — | 1,214,770 | Nov 24, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | PURCHASE | 1,036 | — | — | 1,889 | Nov 24, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | PURCHASE | 1,034 | — | — | 1,888 | Nov 24, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | PURCHASE | 853 | — | — | 853 | Nov 20, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | PURCHASE | 854 | — | — | 854 | Nov 20, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | SALE | 145,994 | — | — | 1,391,690 | Nov 20, 2020 | Nov 24, 2020 ↗ | View → |
| QTRX QUANTERIX CORP | SALE | 229,006 | — | — | 2,182,995 | Nov 20, 2020 | Nov 24, 2020 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 15,183 | — | — | 15,183 | Jun 3, 2020 | Jun 5, 2020 ↗ | View → |
| DNLI DENALI THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 3,253 | — | — | 3,253 | Jun 3, 2020 | Jun 5, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 28,888 | — | — | 28,888 | May 21, 2020 | May 22, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 24,885 | — | — | 24,885 | May 21, 2020 | Oct 13, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 33,184 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 2,750,336 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 1,338,000 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 2,750,335 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,121,520 | — | — | 4,121,520 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,121,519 | — | — | 4,121,519 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |